BR112021022219A2 - Sínteses de oligonucleotídeos em fase líquida convergente - Google Patents
Sínteses de oligonucleotídeos em fase líquida convergenteInfo
- Publication number
- BR112021022219A2 BR112021022219A2 BR112021022219A BR112021022219A BR112021022219A2 BR 112021022219 A2 BR112021022219 A2 BR 112021022219A2 BR 112021022219 A BR112021022219 A BR 112021022219A BR 112021022219 A BR112021022219 A BR 112021022219A BR 112021022219 A2 BR112021022219 A2 BR 112021022219A2
- Authority
- BR
- Brazil
- Prior art keywords
- liquid phase
- oligonucleotide synthesis
- convergent
- phase oligonucleotide
- convergent liquid
- Prior art date
Links
- 239000007791 liquid phase Substances 0.000 title abstract 4
- 238000002515 oligonucleotide synthesis Methods 0.000 title 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845160P | 2019-05-08 | 2019-05-08 | |
| PCT/US2020/032070 WO2020227618A2 (en) | 2019-05-08 | 2020-05-08 | Convergent liquid phase syntheses of oligonucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021022219A2 true BR112021022219A2 (pt) | 2022-03-22 |
Family
ID=70919104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021022219A BR112021022219A2 (pt) | 2019-05-08 | 2020-05-08 | Sínteses de oligonucleotídeos em fase líquida convergente |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12378276B2 (https=) |
| EP (1) | EP3966219A2 (https=) |
| JP (2) | JP7824080B2 (https=) |
| KR (1) | KR20220007104A (https=) |
| CN (3) | CN119462804A (https=) |
| AU (1) | AU2020268415B2 (https=) |
| BR (1) | BR112021022219A2 (https=) |
| CA (1) | CA3139545A1 (https=) |
| EA (1) | EA202193010A1 (https=) |
| IL (2) | IL287798B2 (https=) |
| MA (1) | MA55891A (https=) |
| MX (1) | MX2021013587A (https=) |
| WO (1) | WO2020227618A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013203395A1 (en) | 2012-03-30 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome |
| TWI772856B (zh) | 2013-07-19 | 2022-08-01 | 美商百健Ｍａ公司 | 用於調節τ蛋白表現之組合物 |
| AU2021377229A1 (en) | 2020-11-11 | 2023-06-29 | Biogen Ma Inc. | Oligonucleotides, reagents and preparation thereof |
| PE20240648A1 (es) * | 2021-07-23 | 2024-04-04 | Biogen Ma Inc | Metodos para reducir la expresion de tau |
| WO2024083746A1 (en) | 2022-10-17 | 2024-04-25 | Bachem Holding Ag | Method and composition for oligonucleotide synthesis |
| JP7825064B2 (ja) * | 2022-10-27 | 2026-03-05 | 住友化学株式会社 | オリゴヌクレオチドの製造方法 |
| CN120813558A (zh) | 2023-03-06 | 2025-10-17 | 斯佩拉制药株式会社 | 长链烯氧基取代的苯甲酰衍生物及使用该衍生物的寡核苷酸合成方法 |
| GB202305283D0 (en) * | 2023-04-11 | 2023-05-24 | Exactmer Ltd | Liquid-phase process for preparing oligonucleotides |
| JP7433684B1 (ja) * | 2023-05-24 | 2024-02-20 | 塩野フィネス株式会社 | 疑似固相保護基、それを用いたヌクレオシド保護体又はオリゴヌクレオチド保護体、オリゴアミダイト前駆体の製造方法 |
| EP4695265A1 (en) | 2023-10-16 | 2026-02-18 | Bachem Holding AG | Method and composition for oligonucleotide synthesis |
| US20250206769A1 (en) * | 2023-12-22 | 2025-06-26 | Imec Vzw | Synthesizing a Nucleic Acid or Nucleic Acid Analogue |
| WO2025235761A1 (en) | 2024-05-09 | 2025-11-13 | Biogen Ma Inc. | Reagents and processes for preparing oligonucleotides |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0558749A1 (en) * | 1990-11-20 | 1993-09-08 | Sankyo Company Limited | Antisense nucleic acid derivative |
| US5510476A (en) * | 1994-07-07 | 1996-04-23 | Isis Pharmaceuticals, Inc. | Carbocation scavenging during oligonucleotide synthesis |
| AU738032B2 (en) | 1995-10-19 | 2001-09-06 | Proligo Llc | Method for solution phase synthesis of oligonucleotides |
| EP1386925A1 (en) * | 2002-07-31 | 2004-02-04 | Girindus AG | Method for preparing oligonucleotides |
| SI2548560T1 (sl) | 2005-06-23 | 2015-12-31 | Isis Pharmaceuticals, Inc. | Sestavki in postopki za moduliranje izrezovanja smn2 |
| RU2572826C2 (ru) | 2008-12-02 | 2016-01-20 | Чиралджен, Лтд. | Способ синтеза модифицированных по атому фосфора нуклеиновых кислот |
| JP5548852B2 (ja) * | 2009-05-29 | 2014-07-16 | 国立大学法人東京農工大学 | 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法 |
| PT3305302T (pt) | 2009-06-17 | 2018-12-14 | Biogen Ma Inc | Composições e métodos de modulação de excisões de smn2 em um sujeito |
| US20120184724A1 (en) * | 2009-09-22 | 2012-07-19 | Agilent Technologies, Inc. | Protected monomers and methods of deprotection for rna synthesis |
| JP5705512B2 (ja) | 2010-11-26 | 2015-04-22 | 農工大ティー・エル・オー株式会社 | 高分散性液相支持体を用いたオリゴヌクレオチド合成法 |
| JP5979139B2 (ja) * | 2011-05-17 | 2016-08-24 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| EP2816053B1 (en) | 2012-02-17 | 2021-03-24 | Ajinomoto Co., Inc. | Base-protected oligonucleotide |
| US8846885B2 (en) * | 2012-02-17 | 2014-09-30 | Ajinomoto Co., Inc. | Oligonucleotide with protected base |
| EP2857412B1 (en) * | 2012-05-30 | 2017-01-11 | Hokkaido System Science Co., Ltd. | Oligonucleotide synthesis method using highly dispersible liquid-phase support |
| EP2921499B1 (en) * | 2012-11-14 | 2020-01-22 | Takeda Pharmaceutical Company Limited | Method for liquid-phase synthesis of nucleic acids |
| RS60707B1 (sr) | 2014-04-01 | 2020-09-30 | Biogen Ma Inc | Kompozicije za modulaciju ekspresije sod-1 |
| EP3263579B1 (en) | 2015-01-21 | 2022-11-30 | Ajinomoto Co., Inc. | Precipitation promoter and precipitation method in which same is used |
| WO2017104836A1 (ja) * | 2015-12-16 | 2017-06-22 | 味の素株式会社 | オリゴヌクレオチドの製造方法、およびヌクレオシド、ヌクレオチドまたはオリゴヌクレオチド |
| JPWO2017111137A1 (ja) * | 2015-12-22 | 2018-10-18 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| CN108368166B (zh) | 2015-12-28 | 2023-03-28 | 中外制药株式会社 | 提高含fc区多肽纯化效率的方法 |
| TW201906855A (zh) | 2017-05-02 | 2019-02-16 | 日商日產化學工業股份有限公司 | 寡核苷酸之製造方法 |
-
2020
- 2020-05-08 IL IL287798A patent/IL287798B2/en unknown
- 2020-05-08 KR KR1020217039894A patent/KR20220007104A/ko active Pending
- 2020-05-08 CN CN202411234328.XA patent/CN119462804A/zh active Pending
- 2020-05-08 JP JP2021565931A patent/JP7824080B2/ja active Active
- 2020-05-08 US US17/608,802 patent/US12378276B2/en active Active
- 2020-05-08 MA MA055891A patent/MA55891A/fr unknown
- 2020-05-08 CA CA3139545A patent/CA3139545A1/en active Pending
- 2020-05-08 CN CN202080044020.2A patent/CN114206897B/zh active Active
- 2020-05-08 MX MX2021013587A patent/MX2021013587A/es unknown
- 2020-05-08 EP EP20729413.3A patent/EP3966219A2/en active Pending
- 2020-05-08 AU AU2020268415A patent/AU2020268415B2/en active Active
- 2020-05-08 WO PCT/US2020/032070 patent/WO2020227618A2/en not_active Ceased
- 2020-05-08 EA EA202193010A patent/EA202193010A1/ru unknown
- 2020-05-08 BR BR112021022219A patent/BR112021022219A2/pt unknown
- 2020-05-08 CN CN202411234221.5A patent/CN119143828A/zh active Pending
- 2020-05-08 IL IL319933A patent/IL319933A/en unknown
-
2025
- 2025-07-04 JP JP2025113743A patent/JP2025138846A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MA55891A (fr) | 2022-03-16 |
| WO2020227618A2 (en) | 2020-11-12 |
| KR20220007104A (ko) | 2022-01-18 |
| AU2020268415A1 (en) | 2021-12-23 |
| EP3966219A2 (en) | 2022-03-16 |
| CA3139545A1 (en) | 2020-11-12 |
| EA202193010A1 (ru) | 2022-03-18 |
| WO2020227618A3 (en) | 2021-01-14 |
| AU2020268415B2 (en) | 2026-04-23 |
| US12378276B2 (en) | 2025-08-05 |
| IL287798B1 (en) | 2025-05-01 |
| AU2020268415A8 (en) | 2022-01-20 |
| MX2021013587A (es) | 2022-02-11 |
| JP2025138846A (ja) | 2025-09-25 |
| CN114206897B (zh) | 2024-09-20 |
| CN114206897A (zh) | 2022-03-18 |
| IL319933A (en) | 2025-05-01 |
| JP2022531876A (ja) | 2022-07-12 |
| IL287798A (en) | 2022-01-01 |
| CN119462804A (zh) | 2025-02-18 |
| CN119143828A (zh) | 2024-12-17 |
| WO2020227618A8 (en) | 2020-12-24 |
| US20220348602A1 (en) | 2022-11-03 |
| IL287798B2 (en) | 2025-09-01 |
| JP7824080B2 (ja) | 2026-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021022219A2 (pt) | Sínteses de oligonucleotídeos em fase líquida convergente | |
| CY1123289T1 (el) | Ενωσεις ολιγονουκλεοτιδιων για τη στοχευση του huntingtin mrna | |
| EP3398955A4 (en) | OLIGONUCLEOTIDE MANUFACTURING METHOD AND NUCLEOSIDE, NUCLEOTIDE OR OLIGONUCLEOTIDE | |
| EP3647310A4 (en) | PROCESS FOR THE PREPARATION OF 2,5-FURANDIMETHYL CARBOXYLATE FROM HYDROXYMETHYL FURFURAL | |
| BR112016028273A8 (pt) | derivados radiorrotulados de composto de 2-amino6-fluoro-n-[5-fluoro-piridin-3-il]-pirazol[1,5-a]pirimidin3-carboxamida úteis como inibidor de atr cinase, processo para preparação do referido composto, bem como diferentes formas sólidas do mesmo, uso destas, e composição farmacêutica | |
| NZ703824A (en) | Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell | |
| BR112016010165A2 (pt) | composições de nucleotídeos modificados de citidina-5-carboxamida e métodos relacionados às mesmas | |
| BR112022008061A2 (pt) | Processo eficaz para síntese de 2-amino-5-cloro-n,3-dimetilbenzamida | |
| CR20210200A (es) | Formulación de anticuerpos | |
| IL292191A (en) | Photochemical process for producing (4r,4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide | |
| MX382233B (es) | Composiciones de oligonucleotidos y metodos para realizarlas. | |
| EP3929205A4 (en) | PROCESS FOR PREPARING MODIFIED OLIGONUCLEOTIDE WITH COMPLEMENTARY SEQUENCE | |
| BR112015022618A2 (pt) | processo para a preparação de ácido levulínico | |
| BR112018000481A2 (pt) | ?processos para preparação de compostos e de (-)-ambrox (v)? | |
| EP3677684A4 (en) | METHOD OF PREPARING A FULVIC ACID SOLUTION AND FULVIC ACID SOLUTION | |
| MX389335B (es) | Procedimiento de produccion de e-1-cloro-3,3,3-trifluoropropeno a partir de 1,1,3,3-tetracloropropeno. | |
| BR112018017316A2 (pt) | compostos e métodos para a síntese de 5-(n-protegido-triptaminocarboxiamida)-2?-desoxiuridina fosforamidato para incorporação em uma sequência nucleica | |
| BR112017028128A2 (pt) | ?processo para a preparação de uma poliamida? | |
| BR112017011275A2 (pt) | composição, e, processo para a produção de xarope de glicose. | |
| EP4324811A4 (en) | PROCESS FOR THE PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPEN | |
| WO2016166720A3 (en) | Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives | |
| BR112018070452A2 (pt) | um inibidor do receptor de hutnfr1, uma preparação farmacêutica compreendendo o referido inibidor, um método de produção do referido inibidor, uso do referido inibidor na fabricação de um produto para tratamento de um indivíduo humano, um ácido nucleico isolado que codifica o referido inibidor, vetor de expressão e células hospedeiras compreendendo o referido ácido nucleico | |
| EP3901127A4 (en) | PROCESS FOR THE PRODUCTION OF 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM BUCKLE MOLLUSCS | |
| MX2020005241A (es) | Proceso para la preparacion de fluopicolida. | |
| BR112014019356A8 (pt) | Método para produzir um ou mais produtos finais de fermentação e produto final de fermentação |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |